What is Apollo Hospitals Enterprise Limited (APOLLOHOSP) share price today?

Apollo Hospitals Enterprise Limited (APOLLOHOSP) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/APOLLOHOSP for the latest live price, technical analysis, and AI-powered insights.

How to analyse APOLLOHOSP stock?

VestAI provides comprehensive APOLLOHOSP stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Apollo Hospitals Enterprise Limited in?

Apollo Hospitals Enterprise Limited (APOLLOHOSP) is in the Healthcare sector, Hospital industry on the NSE.

Apollo Hospitals Enterprise Limited

Name: Apollo Hospitals Enterprise Limited (APOLLOHOSP) Financial Metrics
Creator: VestAI
License: https://www.vestai.io/terms

APOLLOHOSP

NSE· Healthcare

₹8,942.00

-108.00 (-1.19%)

52W Low · ₹6,696.5052W High · ₹9,050.00

Near 52W High

Market Cap

₹128787.91L Cr

Volume

1.77L

Prev Close

₹8,820.00

ISIN

INE437A01024

Orion Score

Fundamentals-based quality & risk · not a recommendation

60/100

Watch

Apollo Hospitals Enterprise Limited scores 60/100 (Watch) on the Orion Score — strong business quality (75), strong growth (72), weak balance-sheet safety (49) and rich valuation (14). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.6× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 7/9Altman Z Safe(4.54)Beneish M Clean(-2.52)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

92/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Moderate

D/E 0.85x — manageable leverage

QUALITY

Average

ROCE 18.4% — decent returns

MOMENTUM

Neutral

RSI 63.3 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 66.44
ROCE: 18.41%
ROE (1Y): 21.50%
D/E Ratio: 0.85x
OPM: 11.91%
TTM EPS: ₹134.82
Dividend Yield: 22.00%
Qtrly Sales: ₹6,605.50 Cr
Qtrly Profit: ₹529.30 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹6,605.5	₹529.3	11.9%	₹36.76
Q3 2026	₹6,477.4	₹502.3	11.5%	₹34.94
Q1 2026	₹5,842.1	₹432.8	10.9%	₹30.10
Q4 2025	₹5,592.2	₹389.6	10.0%	₹21.10
Q3 2025	₹5,526.9	₹372.3	10.4%	₹25.89

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2025	₹21,577.4	₹1,445.9	₹3,219.1	10.6%
FY 2024	₹18,862.3	₹898.6	₹2,477.6	9.1%
FY 2023	₹16,444.8	₹819.1	₹2,072.8	8.8%
FY 2022	₹14,536.2	₹1,055.6	₹2,509.2	10.9%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
APOLLOHOSP ★	₹1,28,788 Cr	66.44	18.41%	21.50%	0.85x	11.91%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,921 Cr	26.18	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,665 Cr	109.91	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,073 Cr	38.07	36.31%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹20,657.4	₹16,753.1	₹14,427.8	₹13,269.3
Equity	₹8,212.3	₹6,935.4	₹6,197.4	₹5,623.3
Total Debt	₹5,419.2	₹5,332.6	₹4,332.4	₹4,068.1
Cash	₹578.1	₹505.5	₹433.4	₹546.5
Net Debt	₹2,252	₹2,656.4	₹2,276.9	₹2,089.2
Working Capital	₹2,450	₹615.2	₹1,012.1	₹1,626.3

Shareholding Pattern

Q2 FY2027

Promoter

28.39%

FII

27.12%

DII

22.18%

Public

22.31%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q2 FY2027	28.39% ↑	27.12% ↓	22.18% ↓	22.31% ↑
Q1 FY2027	28.02% ↓	27.79% ↑	22.73% ↑	21.46% ↓
Q4 FY2026	28.38% ↑	24.39% ↓	19.96% ↓	27.27% ↑
Q3 FY2026	28.02%	43.54% ↓	21.5% ↑	6.71% ↑
Q2 FY2026	28.02% ↓	44.2% ↑	21.12% ↓	6.43% ↑
Q1 FY2026	29.34%	43.49% ↑	21.34% ↓	5.61% ↑
Q4 FY2025	29.34% ↑	42.74% ↓	22.29% ↑	5.41% ↑
Q3 FY2025	29.33%	45.27%	19.97%	5.21%

Corporate Actions

Ex-Date	Action	Details
2026-02-16	DIVIDEND	Interim Dividend - Rs 10 Per Sh

Funds Holding This Stock

300 mutual fund schemes

Bandhan Healthcare Fund Direct GrowthIDFC

8.68%

₹27 Cr

DSP Nifty Healthcare Index Fund Direct GrowthDSP

8.07%

₹2 Cr

Aditya Birla Sun Life Pharma & Healthcare Fund Direct GrowthBIRLA_SUN_LIFE

7.31%

₹69 Cr

Bajaj Finserv Healthcare Fund Direct GrowthBajaj Finserv

6.73%

₹22 Cr

LIC MF Healthcare Fund Direct GrowthLIC

6.63%

₹6 Cr

ITI Pharma and Healthcare Fund Direct GrowthITI

6.20%

₹15 Cr

Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

6.04%

₹187 Cr

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct GrowthEDELWEISS

5.83%

₹10 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

5.69%

₹1 Cr

SBI Healthcare Opportunities Fund Direct Plan GrowthSBI

5.37%

₹245 Cr

Analyse APOLLOHOSP with Orion AI

Ask: "Is Apollo Hospitals Enterprise Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock

Apollo Hospitals Enterprise Limited is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE437A01024. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.